publication venue for
- Deintensification of Treatment for Low-grade Bladder Tumors: A Collaborative Review by the International Bladder Cancer Group (IBCG).. 8:179-189. 2024
- Phase 1/2 Randomized Clinical Trial of In-clinic acupuncture Prior to Bacillus Calmette-Guérin in Patients with High-risk Non-muscle-invasive Bladder Cancer.. 7:1431-1440. 2024
- Prognostic Significance of Grade Discrepancy Between Primary Tumor and Venous Thrombus in Nonmetastatic Clear-cell Renal Cell Carcinoma: Analysis of the REMEMBER Registry and Implications for Adjuvant Therapy.. 7:112-121. 2023
- Epidemiology, Screening, and Prevention of Bladder Cancer.. 5:628-639. 2022
- Coffee Intake, Caffeine Metabolism Genotype, and Survival Among Men with Prostate Cancer.. 6:282-288. 2022
- Intermediate-risk Non-muscle-invasive Bladder Cancer: Updated Consensus Definition and Management Recommendations from the International Bladder Cancer Group.. 5:505-516. 2022
- Financial Toxicity Among Patients with Prostate, Bladder, and Kidney Cancer: A Systematic Review and Call to Action.. 4:396-404. 2021
- Mannose Receptor-positive Macrophage Infiltration Correlates with Prostate Cancer Onset and Metastatic Castration-resistant Disease.. 2:429-436. 2018
- Recommendations of Active Surveillance for Intermediate-risk Prostate Cancer: Results from a National Survey of Radiation Oncologists and Urologists.. 2:189-195. 2018
- Staging the Host: Personalizing Risk Assessment for Radical Cystectomy Patients.. 1:292-304. 2018